- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
22
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
22 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EXEL | US$36.20 | 1.5% | 60.1% | US$10.3b | US$35.61 | PE22.1x | E20.5% | n/a | ||
ALNY | US$246.27 | 2.4% | 29.8% | US$31.8b | US$298.97 | PS15.2x | E56.4% | n/a | ||
ITCI | US$126.20 | -0.5% | 89.9% | US$13.4b | US$121.36 | PS21.8x | E52.2% | n/a | ||
SRPT | US$118.00 | -0.7% | -2.6% | US$11.3b | US$184.91 | PE92.5x | E31.8% | n/a | ||
NBIX | US$143.26 | 2.7% | 2.0% | US$14.5b | US$167.67 | PE37.6x | E26.4% | n/a | ||
LLY | US$725.72 | -2.6% | 15.3% | US$653.5b | US$977.47 | PE78.1x | E24.8% | 0.8% | ||
ABBV | US$171.56 | -2.3% | 2.4% | US$303.2b | US$199.93 | PE59.7x | E24.1% | 3.8% | ||
BMY | US$56.29 | 1.0% | 12.3% | US$114.2b | US$61.01 | PS2.4x | E39.3% | 4.4% | ||
INCY | US$71.93 | 0% | 16.3% | US$13.9b | US$79.42 | PE426.6x | E34.1% | n/a | ||
TEVA | US$21.92 | 4.5% | 82.8% | US$24.9b | US$24.95 | PS1.5x | E54.8% | 0% | ||
ONC | US$210.08 | 4.5% | 29.5% | US$22.4b | US$283.39 | PS6.9x | E64.7% | n/a | ||
VRTX | US$422.00 | 2.5% | -4.0% | US$108.7b | US$489.81 | PS10.2x | E36.7% | n/a | ||
GILD | US$91.84 | 0.9% | 15.6% | US$114.5b | US$99.96 | PE908.4x | E31.1% | 3.4% | ||
NTRA | US$158.36 | -4.5% | 138.1% | US$20.9b | US$176.87 | PS13.6x | E55.5% | n/a | ||
ILMN | US$136.67 | 0.1% | -2.9% | US$21.7b | US$161.92 | PS4.9x | E54.8% | 2.3% | ||
MEDP | US$337.35 | 1.9% | 12.8% | US$10.5b | US$343.23 | PE28.6x | E10.9% | n/a | ||
QGEN | US$46.00 | 0.9% | 0.4% | US$10.2b | US$51.14 | PE110x | E34.4% | 2.8% | ||
VTRS | US$11.30 | -3.6% | -4.0% | US$13.5b | US$13.45 | PS0.9x | E51.6% | 4.2% | ||
AVTR | US$22.11 | 1.8% | 0.05% | US$15.0b | US$26.64 | PE48.6x | E29.4% | n/a | ||
TECH | US$75.83 | 1.5% | 4.6% | US$12.0b | US$85.26 | PE80x | E21.1% | 0.4% | ||
BMRN | US$61.53 | -3.6% | -33.9% | US$11.7b | US$97.16 | PE36.4x | E24.1% | n/a | ||
AMGN | US$272.11 | 1.9% | -12.2% | US$146.3b | US$317.24 | PE34.6x | E15.7% | 3.5% |
Page 1 of 1